Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake Medical Dialogues Bureau3 Nov 2019 4:15 AM GMTThe USFDA on Wednesday placed a partial hold on a Novartis trial of the $2.1 million-per-patient gene therapy, Zolgensma after the company informed...
Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA Medical Dialogues Bureau2 Nov 2019 4:00 AM GMTZantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection Medical Dialogues Bureau30 Oct 2019 8:41 AM GMTMumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
New tests shows NO sign of asbestos in recalled JnJ baby powder Medical Dialogues Bureau30 Oct 2019 7:48 AM GMTBut Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA Medical Dialogues Bureau24 Oct 2019 3:50 AM GMTEarly tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report Farhat Nasim26 April 2019 8:50 AM GMTNew Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
Gene therapy for rare form of blindness wins US approval Ruby Khatun Khatun21 Dec 2017 4:34 AM GMTWASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
Skeptical Democrats to quiz Trump health pick on drug prices Ruby Khatun Khatun1 Dec 2017 3:45 AM GMTWASHINGTON: Skeptical Democratic senators are getting a chance to question President Donald Trump's pick for health secretary about what he'll do...
Zydus Cadila gets USFDA nod for swelling reducing drug Ruby Khatun Khatun20 Nov 2017 4:32 AM GMTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
